Loading
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Latest filing published 05 Mar 2013 for MAP Pharmaceuticals, Inc., €57.4M.
Insider track record
Disclosed buys
1
Disclosed sells
0
Signal history
No signal scores available.
Closed purchases
Market purchases
1
Not enough history yet: 0 closed purchases, at least 2 are needed.
Purchases by company
Matthew Mcpherron V: trading record in brief
Matthew Mcpherron V is a declared insider of MAP Pharmaceuticals, Inc., with filings sourced from SEC (Form 4). Over a trading history stretching from 5 October 2007 to 1 March 2013, the count stands at 4 filings.
Every open-market trade on record is a purchase: 1 purchase worth €5.1M, and no sale. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
The latest filing, published on 5 March 2013, reports a transaction of €57.4M in MAP Pharmaceuticals, Inc. The clock since the last published purchase (15 October 2007) now reads 6,948 days. Typically, a trade is published a median of 4 days after it takes place. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Matthew Mcpherron V
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
2,999,526 shares@ US$25.00Common StockSEC:0001181431-13-014374:0
2,285,364 sharesCommon StockSEC:0001181431-07-062139:1
114,162 shares@ US$14.50Common StockSEC:0001181431-07-062139:2
3 of 3 declarations
